Literature DB >> 19854055

Immunolabelling and flow cytometry as new tools to explore dysferlinopathies.

N Wein1, M Krahn, S Courrier, M Bartoli, E Salort-Campana, K Nguyen, C Fernandez, J Pouget, C Fossat, D Depetris, F Leturcq, P Cau, N Levy.   

Abstract

Dysferlinopathies are autosomal recessive muscular dystrophies caused by DYSF mutations, which lead to a reduced amount or a complete lack of dysferlin. One step in dysferlinopathies diagnosis consists in Western blot analysis of proteins extracted from muscle biopsy, or blood monocytes. We have taken advantage of dysferlin expression in monocytes to develop a whole blood flow cytometry (WBFC), using antibodies directed against dysferlin. Six patients were submitted to WBFC analysis and immunofluorescence analysis on monocytes. Results obtained are correlated to Western blot from monocytes and muscle biopsies. The possible usefulness of this flow cytometry analysis in routine diagnosis is presented.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854055     DOI: 10.1016/j.nmd.2009.08.004

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  5 in total

1.  Flow cytometry analysis: a quantitative method for collagen VI deficiency screening.

Authors:  J Kim; C Jimenez-Mallebrera; A R Foley; M Fernandez-Fuente; S C Brown; S Torelli; L Feng; C A Sewry; F Muntoni
Journal:  Neuromuscul Disord       Date:  2011-11-08       Impact factor: 4.296

2.  Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and integrity.

Authors:  Antoine de Morrée; Paul J Hensbergen; Herman H H B M van Haagen; Irina Dragan; André M Deelder; Peter A C 't Hoen; Rune R Frants; Silvère M van der Maarel
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

3.  Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy.

Authors:  Eduard Gallardo; Noemi de Luna; Jordi Diaz-Manera; Ricardo Rojas-García; Lidia Gonzalez-Quereda; Bàrbara Flix; Antoine de Morrée; Silvère van der Maarel; Isabel Illa
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

4.  Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.

Authors:  William Lostal; Marc Bartoli; Carinne Roudaut; Nathalie Bourg; Martin Krahn; Marina Pryadkina; Perrine Borel; Laurence Suel; Joseph A Roche; Daniel Stockholm; Robert J Bloch; Nicolas Levy; Rumaisa Bashir; Isabelle Richard
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

5.  Correction of pseudoexon splicing caused by a novel intronic dysferlin mutation.

Authors:  Janice A Dominov; Özgün Uyan; Diane McKenna-Yasek; Babi Ramesh Reddy Nallamilli; Virginie Kergourlay; Marc Bartoli; Nicolas Levy; Judith Hudson; Teresinha Evangelista; Hanns Lochmuller; Martin Krahn; Laura Rufibach; Madhuri Hegde; Robert H Brown
Journal:  Ann Clin Transl Neurol       Date:  2019-03-03       Impact factor: 4.511

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.